Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions
Clinical trial NCT06871046 · COMPLETED
Trial details
- NCT number
- NCT06871046
- Sponsor
- Teikoku Seiyaku Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-20
- Primary completion
- 2025-09-22
- Enrollment
- 221
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.